Nectar Lifesciences
NECLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Sanjiv Goyal · MD: Sanjiv Goyal · Listing date: July 19, 2005 · Employees: 1693 · Chandigarh · http://www.neclife.com

Stock Price vs Company Growth
1d
0.2%
1w
2.5%
1m
13.8%
3m
7.7%
6m
15.5%
1y
26.0%
5y
18.2%
10y
12.1%
all
1.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 10.8 0.2%
10
13.4
Company Overview

Sales
7.44 Cr
Growth: -11.8%
Profit after Tax
-280 Cr
Growth: -14.6%
Micro Cap
209 Cr
P/S: 28.1x
Industry P/S: 2.9x
Fundamentals

Sales (Cr) ₹ 7.44
Growth -11.8%
EBITDA N/A
P/S 28.1x
Dividend 0.0%
P/E N/A
Book Value ₹ 1
PEG Ratio N/A
ROE -1337.4%
P/B N/A
Shareholding Pattern

Institutions
Nsr Direct Pe Mauritius Llc
14.59 %
Ingain Traders, Llc
1.34 %
Iepf
0.02 %
Promoters
Sanjiv Goyal
31.33 %
Sanjiv (Huf)
24.47 %
Others
Increase    Decrease    No change
Company Profile Detailed

Nectar is a global pharmaceutical company specializing in Cephalosporins.
Investors (30)
Followers (2)